FindTrial
Sign In

124I-JS001 PET/CT to assess PD-1 expression in patients with solid tumors

124I-JS001 PET/CT to assess PD-1 expression in patients with solid tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027666
Enrollment
Unknown
Registered
2019-11-23
Start date
2019-11-25
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

Interventions

Case series:124I-JS001 PET/CT scans

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 (inclusive) years and ECGO 0 or 1; 2. Patients with a confirmed histologic diagnosis of solid tumors; 3. has at least one measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST V1.1); 4. life expectancy >=3 months; 5. patients that would receive treatments with JS001.

Exclusion criteria

Exclusion criteria: 1. Significant hepatic renal dysfunction; 2. Is Pregnant or ready to pregnant; 3. Allergic to research drugs; 4. Cannot tolerate the whole examination during the research; 5. Any other conclusive medical reasons, mental illness, and / or social reasons that determined by the investigators.

Design outcomes

Primary

MeasureTime frame
SUVmax;—

Countries

China

Contacts

Public ContactYang Zhi

Beijing Cancer Hospital

pekyz@163.com+86 010-88196495

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026